Anzahl der Publikationen: 5
Zeitschriftenartikel
Hoster, Eva
ORCID: https://orcid.org/0000-0002-0749-1389; Delfau-Larue, Marie-Hélène
ORCID: https://orcid.org/0000-0002-8010-2343; Macintyre, Elizabeth; Jiang, Linmiao
ORCID: https://orcid.org/0000-0002-9009-4236; Stilgenbauer, Stephan; Vehling-Kaiser, Ursula; Salles, Gilles
ORCID: https://orcid.org/0000-0002-9541-8666; Thieblemont, Catherine
ORCID: https://orcid.org/0000-0002-9941-2448; Tilly, Hervé
ORCID: https://orcid.org/0000-0001-7022-5246; Wirths, Stefan
ORCID: https://orcid.org/0000-0003-2494-9862; Feugier, Pierre; Hübel, Kai; Schmidt, Christian; Ribrag, Vincent; Kluin-Nelemans, Johanna C.
ORCID: https://orcid.org/0000-0003-2617-9427; Dreyling, Martin
ORCID: https://orcid.org/0000-0002-0358-5249 und Pott, Christiane
ORCID: https://orcid.org/0009-0005-9260-8340
(2023):
Predictive Value of Minimal Residual Disease for Efficacy of Rituximab Maintenance in Mantle Cell Lymphoma. Results From the European Mantle Cell Lymphoma Elderly Trial.
In: Journal of Clinical Oncology, Bd. 42, Nr. 5: S. 538-549
Hermine, Olivier
ORCID: https://orcid.org/0000-0003-2574-3874; Jiang, Linmiao
ORCID: https://orcid.org/0000-0002-9009-4236; Walewski, Jan
ORCID: https://orcid.org/0000-0003-4247-2674; Bosly, André; Thieblemont, Catherine
ORCID: https://orcid.org/0000-0002-9941-2448; Szymczyk, Michal; Pott, Christiane; Salles, Gilles
ORCID: https://orcid.org/0000-0002-9541-8666; Feugier, Pierre; Hübel, Kai; Haioun, Corinne; Casasnovas, René Olivier
ORCID: https://orcid.org/0000-0002-1156-8983; Schmidt, Christian; Bouabdallah, Kamal; Ribrag, Vincent; Kanz, Lothar; Dürig, Jan
ORCID: https://orcid.org/0000-0002-7672-3905; Metzner, Bernd; Sibon, David
ORCID: https://orcid.org/0000-0002-9205-625X; Cheminant, Morgane; Burroni, Barbara; Klapper, Wolfram; Hiddemann, Wolfgang; Unterhalt, Michael; Hoster, Eva
ORCID: https://orcid.org/0000-0002-0749-1389 und Dreyling, Martin
ORCID: https://orcid.org/0000-0002-0358-5249
(2022):
High-Dose Cytarabine and Autologous Stem-Cell Transplantation in Mantle Cell Lymphoma. Long-Term Follow-Up of the Randomized Mantle Cell Lymphoma Younger Trial of the European Mantle Cell Lymphoma Network.
In: Journal of Clinical Oncology, Bd. 41, Nr. 3: S. 479-484
Zoellner, Anna-Katharina; Unterhalt, Michael; Stilgenbauer, Stephan; Hübel, Kai; Klapper, Wolfram; Hiddemann, Wolfgang; Dreyling, Martin und Hoster, Eva
(2021):
Long-term survival of patients with mantle cell lymphoma after autologous haematopoietic stem-cell transplantation in first remission: a post-hoc analysis of an open-label, multicentre, randomised, phase 3 trial.
In: The Lancet. Haematology, Bd. 8, Nr. 9, e648-e657
Hess, Georg; Wagner, Karola; Keller, Ulrich; La Rosee, Paul; Atta, Johannes; Hübel, Kai; Lerchenmueller, Christian; Schoendube, Daniel; Witzens-Harig, Mathias; Ruckes, Christian; Medler, Christoph; Oordt, Christina van; Klapper, Wolfram; Theobald, Matthias und Dreyling, Martin
(2020):
Final Results of a Phase I/II Trial of the Combination Bendamustine and Rituximab With Temsirolimus (BeRT) in Relapsed Mantle Cell Lymphoma and Follicular Lymphoma.
In: Hemasphere, Bd. 4, Nr. 3, e398
Mohty, Mohamad; Azar, Nabih; Chabannon, Christian; Gouill, Steven le; Karlin, Lionel; Farina, Lucia; Milkovich, Gary; Ostermann, Helmut; Glass, Bertram; Noppeney, Richard; Kron, Florian; Kron, Anna und Hübel, Kai
(2018):
Plerixafor in poor mobilizers with non-Hodgkin's lymphoma: a multi-center time-motion analysis.
In: Bone Marrow Transplantation, Bd. 53, Nr. 3: S. 246-254
Diese Liste wurde am
Sat Aug 10 19:32:04 2024 CEST
erstellt.